Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1374672-84-0

Post Buying Request

1374672-84-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1374672-84-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1374672-84-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,4,6,7 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1374672-84:
(9*1)+(8*3)+(7*7)+(6*4)+(5*6)+(4*7)+(3*2)+(2*8)+(1*4)=190
190 % 10 = 0
So 1374672-84-0 is a valid CAS Registry Number.

1374672-84-0Relevant articles and documents

Copper(I) Complexes Bearing 1,2-Phenyl-Bridged P∧N, P∧N∧P, and N∧P∧N Chelate Ligands: Structures and Phosphorescence

Zeng, Chao,Wang, Nan,Peng, Tai,Wang, Suning

, p. 1616 - 1625 (2017)

With the aim to obtain new phosphorescent Cu(I) compounds, several new 1,2-phenyl-bridged P∧N, P∧N∧P, and N∧P∧N chelate ligands were designed and synthesized. These ligands were found to form complexes with Cu(I) ion readily via either solution reactions or solid-state grinding process. The new Cu(I) compounds based on this class of ligands display phosphorescence with emission color ranging from blue to red. The structure of the ligand and the nature of the N-heterocycle in the chelate ligands were found to have a significant impact on the phosphorescent properties of the Cu(I) compounds.

A PHENYL TRIAZOLE DERIVATIVE AND ITS USE FOR MODULATING THE GABAA RECEPTOR COMPLEX

-

Page/Page column 14; 15, (2014/01/17)

This invention relates to a novel phenyl triazole derivative, pharmaceutical compositions containing this compound, and methods of treatment therewith. The compound of the invention is in particular considered useful for the treatment of central nervous s

TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS

-

Page/Page column 40, (2012/05/31)

The present invention is concerned with novel triazole compounds of formula (I) wherein A, X, Y, Z, R1, R2, and R3 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. The active compounds of present invention have affinity and selectivity for the GABA A α5 receptor. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1374672-84-0